Independent Prognostic Factors in Patients With Metastatic (Stage D2) Prostate Cancer
- 6 February 1991
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 265 (5) , 618-621
- https://doi.org/10.1001/jama.1991.03460050072023
Abstract
Research from JAMA — Independent Prognostic Factors in Patients With Metastatic (Stage D2) Prostate CancerThis publication has 7 references indexed in Scilit:
- Prognostic Factors in Survival Free of Progression After Androgen Deprivation Therapy for Treatment of Prostate CancerJournal of Urology, 1989
- High Serum Prolactin Associated with Poor Prognosis in Carcinoma of the ProstateBritish Journal of Urology, 1984
- Carcinoma of the prostate: Relationship of pretreatment hormone levels to survivalEuropean Journal of Cancer and Clinical Oncology, 1984
- Correlation of Prostatic Nuclear Androgen Receptor Content with Duration of Response and Survival Following Hormonal Therapy in Advanced Prostatic CancerJournal of Urology, 1982
- Blood hormone profiles in prostate cancer patients in high-risk and low-risk populationsCancer, 1981
- A Cycle of Plasma Testosterone in the Human MaleJournal of Clinical Endocrinology & Metabolism, 1975
- DIURNAL VARIATION OF PLASMA TESTOSTERONE AND CORTISOLJournal of Endocrinology, 1972